Daiichi Sankyo, Inc. (D4S.F) Completes Plexxikon Inc. Acquisition  
4/4/2011 8:50:18 AM

BERKELEY, Calif.--(BUSINESS WIRE)--Plexxikon Inc. today announced that its acquisition by Daiichi Sankyo Company, Limited, a Japan-based global pharmaceutical company, has been successfully completed. Clearance under the Hart Scott Rodino Antitrust Improvements Act has been received. Under the terms of the deal, Plexxikon shareholders will receive $805 million up-front, with near-term milestone payments associated with the approval of PLX4032 totaling an additional $130 million. Plexxikon will retain its name, employees and facilities in Berkeley, CA, and continue research and development operations as an independent unit of Daiichi Sankyo.